Written by UNIC Team | Jun 8, 2026, 6:45:00 AM
Last week, we held an event entitled ‘Integrity in the Pharmaceutical Sector: Challenges, Risks and Practical Solutions’, which proved to be one of the largest and most substantive in our series of industry discussions.
The panel brought together eight speakers and a moderator, enabling a comprehensive discussion of key issues relating to integrity and compliance in the pharmaceutical sector.
Thanks to the diverse backgrounds of the participants — ranging from representatives of the public sector to leading pharmaceutical companies — the discussion was in-depth, substantive and rich in practical insights. The discussion covered both systemic challenges and specific tools and approaches that are already being implemented by businesses to strengthen integrity and compliance.
We would like to thank the event moderator, Lana Sinichkina, Chair of the UNIC Supervisory Board and Partner at Arzinger, for her professional moderation of the discussion and skilful steering of the conversation around the most pressing challenges and practical solutions regarding integrity and compliance in the pharmaceutical sector.
Special thanks to the event partners:
🤝 Arzinger — for hosting and supporting the event
🤝 Servier Ukraine — for industry partnership
We sincerely thank all the speakers, partners and participants who joined the discussion and made it truly meaningful, professional and valuable.
📌 In our upcoming posts, we will share more details on the key takeaways and insights from the event. Stay tuned for our updates!
ℹ️ The International Conference and Business Integrity Month events are implemented with the support of the Main General Partner, VKURSI Big Data Platform, and General Partners Arzinger, SPP Development Ukraine and International Medical Corps.
Main Information Partners of Business Integrity Month: American Chamber of Commerce in Ukraine and European Business Association.